These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24196026)

  • 21. Cognitive control deficits during mecamylamine-precipitated withdrawal in mice: Possible links to frontostriatal BDNF imbalance.
    Parikh V; Cole RD; Patel PJ; Poole RL; Gould TJ
    Neurobiol Learn Mem; 2016 Feb; 128():110-6. PubMed ID: 26775017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice.
    Biala G; Staniak N
    Pharmacol Biochem Behav; 2010 Aug; 96(2):141-7. PubMed ID: 20451547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
    Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
    Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotine withdrawal in adolescent and adult rats.
    O'Dell LE; Bruijnzeel AW; Ghozland S; Markou A; Koob GF
    Ann N Y Acad Sci; 2004 Jun; 1021():167-74. PubMed ID: 15251887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex differences in the reward deficit and somatic signs associated with precipitated nicotine withdrawal in rats.
    Tan S; Xue S; Behnood-Rod A; Chellian R; Wilson R; Knight P; Panunzio S; Lyons H; Febo M; Bruijnzeel AW
    Neuropharmacology; 2019 Dec; 160():107756. PubMed ID: 31487496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mecamylamine-precipitated nicotine-withdrawal aversion in rats.
    Suzuki T; Ise Y; Tsuda M; Maeda J; Misawa M
    Eur J Pharmacol; 1996 Oct; 314(3):281-4. PubMed ID: 8957247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bupropion attenuates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Smith TD; Khambati HN; Meyers-Paal RL; Montellano AL; Jennings RE; Erwin DS; Presley SE; Perales BA
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):494-503. PubMed ID: 16163521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnitude of open-field thigmotaxis during mecamylamine-precipitated nicotine withdrawal in rats is influenced by mecamylamine dose, duration of nicotine infusion, number of withdrawal episodes, and age.
    Harris AC
    Pharmacol Biochem Behav; 2021 Jun; 205():173185. PubMed ID: 33831460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mecamylamine acutely increases human intravenous nicotine self-administration.
    Rose JE; Behm FM; Westman EC; Bates JE
    Pharmacol Biochem Behav; 2003 Sep; 76(2):307-13. PubMed ID: 14592683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GABA
    Varani AP; Pedrón VT; Aon AJ; Canero EM; Balerio GN
    Biomed Pharmacother; 2021 Aug; 140():111786. PubMed ID: 34144406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction.
    O'Dell LE; Bruijnzeel AW; Smith RT; Parsons LH; Merves ML; Goldberger BA; Richardson HN; Koob GF; Markou A
    Psychopharmacology (Berl); 2006 Jul; 186(4):612-9. PubMed ID: 16598454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice.
    Ponzoni L; Moretti M; Sala M; Fasoli F; Mucchietto V; Lucini V; Cannazza G; Gallesi G; Castellana CN; Clementi F; Zoli M; Gotti C; Braida D
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1775-86. PubMed ID: 26141510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats.
    Ise Y; Narita M; Nagase H; Suzuki T
    Psychopharmacology (Berl); 2000 Jul; 151(1):49-54. PubMed ID: 10958116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Carter VA; Cunningham JS; Hebert KM; Conrad DL; Wilson OB
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):180-4. PubMed ID: 7862893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of src-kinase attenuates naloxone-precipitated opioid withdrawal syndrome in mice.
    Rehni AK; Singh N
    Behav Pharmacol; 2011 Apr; 22(2):182-90. PubMed ID: 21285874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time-dependent changes in nicotine behavioral responsivity during early withdrawal from chronic cocaine administration and attenuation of cocaine sensitization by mecamylamine.
    Szabo ST; Fowler JC; Froeliger B; Lee TH
    Behav Brain Res; 2014 Apr; 262():42-6. PubMed ID: 24412684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Removal of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in mice.
    Kwilasz AJ; Harris LS; Vann RE
    Pharmacol Biochem Behav; 2009 Nov; 94(1):114-8. PubMed ID: 19660491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral characterization of early nicotine withdrawal in the mouse: a potential model of acute dependence.
    Kim B; Im HI
    Behav Brain Funct; 2024 Jan; 20(1):1. PubMed ID: 38218838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.
    Castañé A; Valjent E; Ledent C; Parmentier M; Maldonado R; Valverde O
    Neuropharmacology; 2002 Oct; 43(5):857-67. PubMed ID: 12384171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation of mecamylamine-precipitated nicotine-withdrawal aversion by the 5-HT3 receptor antagonist ondansetron.
    Suzuki T; Ise Y; Mori T; Misawa M
    Life Sci; 1997; 61(16):PL249-54. PubMed ID: 9353175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.